The nature of anemia formation in lead poisoning is still unknown, especially of its mechanism. Rimington proposed a hypothesis that lead interferes with a specific enzyme (ferrochelatase) system, which is responsible for incorporating iron into the protoporphyrin IX molecules to form heme. In the present study, heme synthesis in mitochondria (Mt) of liver and bone marrow, and
59 Fe behavior in vivo were investigated in rabbits to verify his hypothesis. The experimental five groups were as follows: 1) lead (Pb) poisoning by administration of 10-20 mg Pb/kg at a time, subcutaneously injected 10 times in all during 30 days, 2) phenylhydrazine (PH) poisoning, 10 mg PH/kg, 3 times subcutaneously during 3 days, 3) bleeding of about 105 ml of blood in total by venesection through 7 times treatments, 4) low feeding, synthetic feeding pellets of 30 g/d/cap. or 70 g/d/cap. 5) control, by administration of 5% glucose instead of lead injection with 120 g/d/cap. of the feeding pellets, with drinking water 300 ml/d/cap. for 30 days.
59 Fe-plasma was prepared by the following procedure: 5 ml of plasma from each rabbit having been incubated with 5 μCi of
59 Fe citrate at 37°C for 30 minutes,
59 Fe-plasma was purified partially by Borova's method. The prepared
59 Fe-plasma was injected intravenously into the rabbits in each group. Urinary coproporphrin (CP-U), eythrocyte protoporphyrin (FFP), Hb, Ht, MCHC, reticulocyte (Rt), and protoheme formed by Mt, were determined to examine the relationship between lead and porphyrinheme metabolism.
59 Fe behavior was estimated by detecting the plasma iron disappearence rate (half life time of
59 Fe in plasma),
59 Fe intake into erythrocytes, and the retention of
59 Fe in tissues. Increase of FEP in lead poisoning was not caused by hemolysis, because FEP did not increase in PH group (Table 1). CP-U slightly increased in PH group, but not in the bleeding group (Table 2). This increase of CP-U must be due to acceleration of hematopoiesis in PH poisoning, because PH and bleeding groups showed an increase of Rt, counting 222.2 and 85.3‰, respectively, at the termination of the treatment, while the Pb group did not show any obvious reticulocytosis (Table 3). PH, bleeding, and Pb (10 mg/kg) groups showed shorter half life time of
59 Fe in plasma, while the 30 g/d-feeding group showed longer time (Table 8). During 100 minutes after
59 Fe injection, incorporation of
59 Fe into erythrocytes was higher in PH and bleeding groups than those in othr treatment groups and the control (Table 9). During 5 days after
59 Fe administration,
59 Fe incorporation was lower in Pb group, but higher in PH and bleeding groups (Figs. 2 and 3). Pb group and the control group showed almost simillar
59 Fe activities in the liver (Table 10). Much incorporation of
59 Fe into spleen was observed in PH group (Table 11). On the other hand, much retention of
59 Fe was detected in the bone marrow and its Mt of the animals of Pb group, but not in the groups of bleeding and PH (Tables 11 and 13). These results indicate that the heme synthetase (ferrochelatase) is inhibited by lead, inspite of much accumulation of
59 Fe in bone marrow and in its Mt. This suggests that Fe in Mt is not effectively utilized for heme formation in lead poisoning.
View full abstract